["7.3 billion", "Middle East respiratory syndrome", "the identification of the most severely affected cases and decline as the epidemic progresses.", "January 30, 2020", "H7N9", "a series of modeling articles", "20% to 30%", "20%", "less than 1", "35\u202f000 to 60\u202f000", "HMPV", "there are no approved vaccines or medications", "other respiratory viruses", "protect against infection across diverse viral isolates", "antibodies that prevent disease when given prophylactically", "hybridoma technology", "flow cytometry", "new diagnostic, therapeutic, and research reagents", "could protect against HIV acquisition", "use of microfluidics and robotics", "identification of B cells that target this relatively conserved site", "protection", "various methods have been developed to understand antigen-specific B cell responses", "2012", "21% [5, 6]", "female, aged 18, presenting in winter will be less likely to be diagnosed", "Dromedary camels", "11-13 days", "16 days", "acute pneumonia", "male", "bronchitis [18] and pneumonia", "bronchitis [18] and pneumonia", "NK cells", "reactive oxygen species (ROS)", "ROS", "June 30, 2017", "to meet the health needs", "a lowincome or middle-income country", "proven leader and advocate", "primer sets", "Coronavirus OC43", "2-5 times higher", "continent of Africa", "subjects under 6 years", "severe illnesses", "Coronavirus OC43", "13.3%, 10/75", "12.5%", "circulation patterns", "active community surveillance", "medical applications", "colorectal cancer", "83.2% and 64.3%", "83.2% and 64.3%", "by detection of nuclear condensation", "apoptotic chromatin changes", "mitochondrial membrane potential", "untreated, treated, and TNF-stimulated", "weak", "HCQ", "The outbreak of coronavirus disease 2019", "inhibiting virus entry", "high concentration of cytokines", "Wuhan, China", "34,598", "a new forecasting model", "GA-SSA-ANFIS", "local search method for FPA", "has a high ability to predict the number of confirmed cases within ten days", "FPASSA-ANFIS", "optimizing its parameters", "better performance", "using a modified FPA algorithm", "good performances", "COVID-19", "humans, birds, livestock, mice, bats, and other wild animals", "time series prediction and forecasting problems", "flexibility in determining nonlinearity in the time series data", "various forecasting", "individual swarm intelligence", "particle swarm optimization", "sine-cosine algorithm", "multi-verse optimizer", "sine-cosine algorithm", "individual SI algorithms may stock at local optima", "ordered weighted averaging", "a modified version", "flow pollination process of the flowering plants", "the behavior of salp chains", "flower pollination algorithm", "by receiving the historical COVID-19 dataset", "FPASSA-ANFIS method", "In case the patient load exceeds the hospital capability of the IDH", "the size of the patients' population", "Critical care response", "highly contagious with multiple transmission route", "susceptible-exposed-infectious-recovered", "bat beta-coronaviruses", "1,000", "chimeric SL-SHC014-MA15 virus", "\u223c80%", "99.8% homology", ">5,000 nucleotides", "SL-SHC014-MA15 virus", "absence of a logical targeted pattern in the new viral sequences", "construction of a chimeric CoV with a bat CoV S gene", "significant divergence", "by serial passage of an infectious wildtype SARS CoV clone", "due to six coding genetic mutations associated with mouse adaptation", "mouse adaptation", "may not be necessary", "several novel bat coronaviruses were isolated from Chinese horseshoe bats", "it was proposed that an intermediate host may not be necessary", "bat ACE2 gene has been positively selected at the same contact sites", "13]", "gain of function (GOF) studies", "laboratory-engineered CoV", "that SARS-CoV-2 is of laboratory origin", "No potential conflict of interest", "withdrawn this report", "stepwise and accrues mutations gradually over time", "the authors who made the initial claim have already withdrawn this report", "the authors who made the initial claim have already withdrawn this report", "SARS-CoV", "12 December", "China", "2002", "31 December", "26 January 2020", "4 weeks", "reverse transcription polymerase chain reaction", "1000", "10 days", "coronavirus", "2012", "4 weeks", "3%", "34%", "volume and diversity of the information available and the relative lack of verification mechanisms", "autoinfection", "Autoinfection", "around 3", "where a case infected significantly more contacts than the average", "up to 5 m", "contingency plans", "disease tolerant and other patients less tolerant to the viral infection", "betacoronavirus", "betacoronavirus", "2003", "8000", "35-50%", "35-50%", "double membrane vesicles (DMVs)", "excessive inflammatory response", "presence of pulmonary edema and respiratory failure without a cardiac cause", "cell host response", "Host resilience", "dysregulates the host transcriptome", "severe lung pathology", "MERS-CoV is not as widespread", "double membrane vesicles", "it appears to have an even higher mortality rate", "2016-07-01", "uses the ACE2 receptor", "decrease mortality", "common targets of many viruses", "increased pathogen burden", "can protect against inflammation-induced death", "the ability of a host to tolerate the effects of an infection", "They act to stabilize the activation of aspects of the innate immune response", "ARDS patients", "obese", "it appears to have an even higher mortality rate", "SARS-CoV also spreads more rapidly between hosts", "many other viruses cause ALI and ARDS", "systematic searches for diagnosis, therapeutic drugs and vaccines", "over 25,000", "2%", "MERS and SARS", "fever, cough, and myalgia or fatigue", "betacoronavirus", "Sarbecovirus", "Middle East respiratory syndrome coronavirus (MERS-CoV)", "about 3%", "higher", "PubMed, Embase and Cochrane Library", "to identify published studies", "published studies", "One randomized controlled trial investigating integrative western and Chinese treatment", "published studies", "RT-PCR", "specimens collected from the lower respiratory tract", "lopinavir and ritonavir", "real-time", "real-time", "high levels of PCR inhibition may hinder PCR sensitivity", "better sensitivity and specificity", "inhibit two coronavirus enzymes", "10 genome equivalents per reaction", "10 genome equivalents per reaction", "MERS-CoV outbreak", "RT-PCR", "usage of a specific Chinese medicine", "Phase I clinical trials on SARS or MERS vaccines", "potentially lower viral loads and may have higher risk of false-negatives", "achievement of favorable clinical outcomes", "nine", "there are nine clinical trials registered under the clinical trials registry", "86% and 94% participants after 2 and 3 doses", "Neutralising antibodies were detected in 50% participants", "71% and 76% participants after 2 and 3 doses, respectively", "There were no differences in immune responses between dose groups after 6 weeks", "restoration of affected populations to good health following infections", "SARS-CoV inhibitors", "SARS-CoV diagnostic testing", "The likely earliest Phase 1 vaccine trial is a synthetic DNA-based candidate", "key pharmaceutical interventions to limit transmission of respiratory infectious diseases", "closure of high-risk facilities", "detecting the genetic material of the virus", "lack of knowledge of the presence of viable virus", "need to collect paired serum samples", "There are some limitations for the assay", "All patients recovered", "obvious", "higher and more prolonged levels of viral RNA", "longer viral shedding", "insufficient organisms", "reverse transcription-polymerase chain reaction (RT-PCR)", "not available or accessible", "Germany", "from the systematic review", "The systematic searches for diagnosis, therapeutic drugs and vaccines were carried out independently", "Both Phase I clinical trials reported positive results", "to be safe and well-tolerated at single doses", "pyrin domain-containing 3", "Ca 2+ -permeable ion channels", "ion channel activity of the 3a protein", "transmembrane pore-forming viral proteins", "Betacoronavirus", "Betacoronavirus within the family Coronaviridae", "is an enveloped", "single-stranded", "8,098", "9.6%", "cathepsin B and L", "by sensing the cellular damage or distress induced by viroporins", "76", "Ca 2+ -permeable", "NLRP3 inflammasome", "older adults", "easily from person-to-person", "50", "March 16", "isolate at home", "betacoronavirus", "camels, cattle, cats, and bats", "recognition, initiation, and acceleration phases", "acceleration phase", "heart disease, lung disease and diabetes", "rRT-PCR", "bats", "Nonpharmaceutical interventions", "coronavirus 2", "December 2019", "Wuhan, China", "daily air travel volume", "\u22486 days", "2012", "Jordan", "Corman et al.", "camel shepherds", "across the Arabian Peninsula and in parts of Africa", "isolation treatment facility", "Droplet spread", "lengthy exposure", "KSA", "lower respiratory tract (LRT) disease", "fever, cough, breathing difficulties and pneumonia", "bat and in many dromedary camels (DC)", "Older males", "unfamiliarity of local clinicians with MERS", "68 M", "healthcare workers", "widespread evidence of past infection in adult camels and limited past exposure among humans", "first viral isolate was patented", "on the website of the professional emerging diseases (ProMED) network", "20 th September 2012", "a 60 year old man from Bisha", "1,493", "189", "a virus", "relatively close and prolonged exposure", "The first viral isolate", "hospital-acquired", "exopeptidase dipeptidyl peptidase 4", "inferior", "inferior", "from infected to uninfected humans in close and prolonged contact", "Older males", "severe, and therefore more obvious, illness", "common cold", "illness", "five to six days", "13 to 14 days", "11 to 13 days", "week three", "genetic recombination", "79 %", "higher association between fatal MERS and older males with underlying comorbidities", "fever, cough and upper respiratory tract (URT)", "pneumonia", "acute respiratory distress syndrome and multiorgan system failure [37] .", "35 %", "35 %", "36 deaths", "PCR-based techniques", "first open reading frames", "disease was first noticed there", "Detection of viral proteins", "94 %", "100 %", "monoclonal antibody-based capture ELISA", "Paired sera, collected two to three weeks apart", "low transmission rate that has prevented worldwide spread, despite many \"opportunities\".", "low transmission rate that has prevented worldwide spread, despite many \"opportunities\".", "confirmatory IFA", "whether such cases are able to infect others", "if only mild disease or asymptomatic infection results", "testing for other respiratory pathogens [53]", "virus culture in Vero and LLC-MK2 cells", "whole genome sequencing is applied", "A and B", "two weeks after onset of disease", "12 to 26 days", "long periods", "Over three quarters", "at least 30 days", "30 %", "tracheal aspirates and BAL", "nasopharyngeal aspirates", "nasopharyngeal aspirates", "bronchoalveolar lavage", "nearly 40 %", "nearly 40 %", "low transmission rate", "animal MERS-CoV infections", "virus or viral RNA", "seropositive and RNA or virus negative", "between late October and late February", "new infections among na\u00efve DC populations", "camel shepherds", "at least 72 h later", "at least 72 h later", "pasteurization", "24 h [150]", "45 min", "4 m", "Droplet spread between humans", "blue bars", "blue bars", "blue bars", "blue bars", "blue bars", "around 3 %", "easily transmitted", "the average number of infections caused by one infected individual in a fully susceptible populationhas", "the average number of infections caused by one infected individual in a fully susceptible populationhas", "ongoing, sporadic spill-over events", "acute LRT disease", "Jordan", "43 %", "21 %", "16 %", "Analyses", "only human-derived MERS-CoV genomes", "blue vertical bars", "two", "Riyadh", "Riyadh", "from infected to uninfected humans", "poor infection control in health care settings", "nearly 40 %", "Global alignment of case definitions", "more proinflammatory response", "There is no evidence", "met the WHO criteria", "timely", "air disinfection", "establishment of the\nCT procedures", "N95", "1 mm-thick", "up-to-date case definitions and information about\nconfirmatory tests", "appropriate isolation measures", "to understand the\nextent and dynamic evolution of lung lesions", "can reduce the radiation damage to patients", "data gathering, collaboration, needs assessment, and expert advice", "four areas", "barriers", "administrative office and the diagnostic room", "fever-CT control room,\nfever-DR control room", "access areas for medical personnel and a dressing area for technologists", "in accordance with the procedures and under the supervision of\nthe infection control nurse", "periodically taking time off", "Pregnant staff", "data gathering, collaboration, needs assessment, and expert advice", "All authors read and approved the final manuscript", "6", "3,169", "whom13,701", "December 2019", "pneumonia", "real-time PCR", "positively correlated", "12", "positively correlated", "SARS-Coronavirus", "positively correlated", "caused pneumonia", "endothelial cells", "coronavirus replication in pulmonary alveolus", "many proteins", "RP transmission model", "Reservoir-People (RP) transmission network model", "2.30 from reservoir to person and 3.58 from person to person", "Berkeley Madonna displays the root mean square deviation between the data", "importation", "we set the infectious period of the cases as 5.8 days", "four compartments", "five compartments", "the seafood market", "five compartments", "5.2 days", "5-day", "3 to 7 days", "5.8 days", "50%", "0.3 million", "about 2.87 million", "0.5 times that of symptomatic infection", "R 0", "R 0", "half of that of symptomatic infection", "R 0", "people and viruses have different dimensions", "develop a mathematical model for calculating the transmissibility of the virus", "spherical, enveloped, and the largest of positive-strand RNA viruses", "birds, farm animals, pets, camels", "199", "2 to 4 February 2020", "102 and 47 cases", "a passenger who started coughing from 19 January 2020 on board", "on 1 February", "199", "5.0 days", "greatly reducing the number of secondary transmissions on board", "1373", "late December 2019", "63.1 million", "100q = 2.1%", "debates are ongoing about their protective value for uninfected persons", "because it has direct implications for public health and hospital infection control", "10 days", "from person to person", "2.2", "6 days, with an upper limit of around 11-14 days", "a slightly lower basic reproductive number", "Control measures and changes in population behaviour", "11-14 days", "more than 75,000", "on the day of illness onset", "through large respiratory droplets", "from person to person", "susceptibility vs severity", "faecal-oral transmission", "faecal-oral", "through a surveillance system for pneumonia", "there could be many more mild infections than severe infections", "Serosurveys in affected locations", "high risk groups", "older adults", "when not all exacerbation events occurred during the viral infection", "viral infection increases airway inflammation", "The mechanism of the occurrence of secondary cilia dyskinesia", "Respiratory virus infection", "viral interaction with the upper airway", "viral interactions with the airway epithelium", "classical mechanisms of viral induced acute exacerbations", "recent findings of viral interaction with the upper airway", "the understanding of viral induced exacerbation in chronic airway inflammatory diseases", "airway inflammation", "host", "the complexity and heterogeneity of the disease", "type 2-skewed inflammatory response", "induction of vasodilation or tight junction opening factors", "morbidity and sometimes mortality in patients", "non-classical symptoms of chronic airway inflammatory diseases", "type 1 immunity that facilitates viral clearance", "viral infection", "high", "ease of transmission and infection", "exacerbations", "induction of vasodilation or tight junction opening factors", "dysregulated inflammation", "upper airway", "viral interaction with the upper airway", "Authors: Tan, Kai Sen", "bacterial infections", "more viruses were recovered during acute exacerbations events", "RV, RSV, and IFV", "RV and RSV", "Rhinovirus (RV)", "they can infect both the upper and/or lower airway", "within airway epithelial cells", "the cells release antiviral factors and cytokines", "type 1 inflammatory responses", "impaired or aberrant", "recent findings of viral interaction with the upper airway", "we highlight recent data regarding viral interactions with the airway epithelium", "greatly affect the patients' quality of life", "increase neutrophilic activation", "increase neutrophilic activation", "airway inflammatory diseases", "increased susceptibility to viral infections", "heighten expression in an inflamed airway", "frequency of exacerbation as a whole", "neutrophilic", "IL-25, IL-33 and TSLP", "IL-4, IL-5, and IL-13", "massive damage", "alteration in the ciliary gene expression", "increased ILC2 activation", "do not activate an ILC2 response", "increase neutrophilic activation", "acute exacerbation", "viral infection", "nasal epithelium remains the primary site of most infections", "more complex interplay between the virus and upper airway epithelium", "dysregulated inflammation", "impaired or reduced ability of viral clearance", "the current scarcity of antiviral drugs", "recent findings of viral interaction with the upper airway", "Patients with chronic airway inflammatory diseases", "type 2-skewed inflammatory response", "developed nations", "changes in immune responses throughout the upper and lower airways", "prolong airway inflammation", "alter local airway inflammation and airway niche", "human papilloma virus", "acute exacerbation", "continuous expression of antiviral genes", "aggravates disease symptoms", "Cell and Developmental Biology", "CoV", "massive damage and cell death to the epithelial barrier", "compounds the cell deaths in IFV infected epithelium", "aberrant epithelial response, contributing to exacerbations", "worsening the inflammation", "impaired or reduced ability of viral clearance", "induction of vasodilation or tight junction opening factors", "increase neutrophilic activation", "Upper Airway Epithelium", "biofilm colonies", "Upper Airway Epithelium", "circulating miRNA changes", "promote a Type 2-biased immune response", "ciliary gene expression", "impaired bacterial immune response", "resolution of the inflammatory response and clearance of the viral infection", "further alter the local environment", "This will improve the quality of life of patients with chronic airway inflammatory diseases", "disruption of mucociliary function", "airway epithelial cells", "increase contact between environmental triggers with the lower airway and resident immune cells", "oxidative stress", "modulation of miRNAs and epigenetic modification", "pathogenic bacteria", "worsening the inflammation", "RV, RSV, and IFV", "increases airway inflammation", "disrupt the equilibrium of the mucociliary function", "more foreign material and allergen to enter the airway", "short non-coding RNAs", "viral infections", "circulating miRNA changes", "infected epithelium and responding immune cells", "increase miR-21 and augmented inflammation", "induce strong type 1 inflammation and cell death", "miR-22 was shown to be suppressed", "targets to modulate viral induced airway changes", "epigenetic modifications", "association of epigenetic modification and chronic airway inflammatory diseases", "systemic mechanisms of acute exacerbation", "antiviral factors", "steroid resistance", "acute exacerbation", "oxidative stress", "alter the epithelial barrier", "increase neutrophilic activation", "increases airway inflammation", "important information", "metagenomics", "to identify systemic mechanisms of acute exacerbation", "humanized mouse model that possess human immune cells", "best mode of verification of the associations", "complex interactions between the host and the exacerbation agents", "infections and deaths", "11th March", "59,000", "case isolation", "Bayesian hierarchical model", "We propose a plausible structure for the infection process and then\nestimate parameters empirically", "We propose a plausible structure for the infection process", "2-3 weeks", "reduce COVID-19\nmortality and healthcare demand", "infections will increase", "23rd January", "downward trend in the number of\nconfirmed new cases during February", "local and national Iockdowns", "downward trend in the number of\nconfirmed new cases during February", "A shorter assumed serial interval", "back-calculate infections from\nobserved deaths", "9.8%", "between 1.88% and 11.43%", "Denmark", "11.43%", "11.43%", "1.1%", "Country %", "11.43%", "Country %", "Country %", "11.43%", "11.43%", "11.43%", "11.43%", "Rt", "different trends may be in place in different parts of each\ncountry", "close spacing of interventions in time", "number of daily infections", "a semi-mechanistic Bayesian hierarchical model", "Public events\nbanned", "mild", "SARS-CoV-Z", "isolation if travelling back from an epidemic country such as China", "banning all public events of more than 100 participants such as\nsports events", "Iockdowns", "Iockdowns", "Public events\nbanned", "time from infection to the onset\nof symptoms", "time from the onset of symptoms to death", "adjusted for the age structure and contact patterns of\neach country", "the initial reproduction number before interventions and the effect sizes from\ninterventions", "infection to onset of symptoms or infection-\nto-onset", "infection to onset of symptoms or infection-\nto-onset", "59 12/3/2020\n\n\n9", "55", "55", "discrete renewal process", "changes in the\nreproductive number", "attack rates", "5.9 [1.9-15.2] million", "through multiple routes", "respiratory tract and then induced pneumonia", "unreliable results from oral swabs detection", "unreliable results from oral swabs detection", "serology", "Patients were sampled without gender or age preference unless where indicated", "obese", "Data on 38 of these cases", "27 January 2020", "47", "the WHO European Region", "42", "25", "3,089", "12 January 2020", "coronavirus", "United Kingdom", "38 cases studied", "a WHO standard COVID-19 case report form", "inform country preparedness; and improve further case detection and management", "describe the key epidemiological and clinical characteristics", "a confirmed case", "15 February", "up to 14 days", "community transmission", "Asia", "16", "to isolate the person rather than because of severe disease", "between 0 and 10 days", "5.7 days", "most were hospitalised to isolate the person rather than because of severe disease", "31", "Two", "screening following repatriation and during contact tracing", "nine", "16", "seven", "five", "five had no pre-existing conditions", "two", "benign", "admitted to intensive care", "hospitalised for 21 days", "13 days", "according to specific assays targeting at least two separate genes", "two clusters in Germany and France, 14 were infected in China.", "4,250", "sporadic cases among travellers from China (14 cases)", "delayed isolation of further local cases", "contact tracing and quarantine", "a history of travel to China", "All cases were confirmed according to specific assays targeting at least two separate genes", "complete a WHO standard COVID-19 case report form", "to help plan for the impact on the healthcare system and the wider population", "to understand the proportion of cases who are asymptomatic", "All cases were confirmed according to specific assays targeting at least two separate genes", "Testing of suspected cases based on geographical risk of importation", "to help identify evidence of widespread community transmission", "to complement surveillance data", "exponential", "estimated at 2.56", "2.56", "21-fold (95% CI: 18-25)", "2.56", "between 1 and 15 January 2020", "Wuhan, China in December 2019", "fever, cough, and shortness of breath", "41", "2066", "Thailand, Japan, Republic of Korea, Hong Kong, Taiwan, Australia", "4000", "Wuhan Municipal Health Commission", "a research group at Imperial College London", "as an exponential growing Poisson process", "as an exponential growing Poisson process", "we performed phylogenetic analysis and multiple alignments", "closest human pathogenic virus to the 2019-nCoV", "two stretches of deletions in the spike receptor binding domain", "completely novel short protein", "hunting for the animal source of 2019-nCoV", "enveloped, positive-sense, single-stranded RNA viruses", "SARS-related CoVs", "its receptor usage, interspecies transmission and pathogenesis", "SARS-CoV and MERS-CoV", "Wuhan", "2 \u03b1CoV", "self-limiting upper respiratory infections", "lacked the C-terminal nucleus localization signal", "pathogenesis", "a 2019-nCoV complete genome", "2019-nCoV HKU-SZ-005b", "strains collected from human, bats, and Himalayan palm civet", "using MEGA X software", "using the Poisson correction method", "phylogenetic analysis and multiple alignments", "RNAfold WebServer", "single-stranded", "38%", "similar", "orf3b, Spike and orf8", "a signal peptide", "conserved fusion peptide", "preventive and treatment modality for testing in animal models before clinical trials", "82%", "external subdomain", "RBD are located in the external subdomain", "its receptor usage", "82%", "Yunnan strains such as the WIV1", "can use human ACE2 as a cellular entry receptor", "suckling rats", "The two retained deletion sites in the Spike genes", "its receptor usage, interspecies transmission and pathogenesis", "recombination hot spots", "fulllength orf8 [23", "2019-nCoV", "Betacoronavirus lineage B coronaviruses", "distant", "trigger intracellular stress pathways", "likely encodes a secreted protein with an alpha-helix", "Figure 7", "Wuhan, Hubei Province, China", "Eurosurveillance", "E and RdRp", "negative progression and adverse outcomes", "twice more likely", "information is rapidly evolving and the science is not yet fully understood", "Wuhan City", "January 15, 2020", "January 24, 2020", "Orange and Los Angeles Counties, California", "January 30, 2020", "6", "January 31, 2020", "Fever and cough", "some patients may present as only mildly ill or asymptomatic altogether", "some mildly ill or potentially even asymptomatic patients", "23", "via contact with infected animals", "It is possible that the virus will undergo mutations over time", "Over 168 million", "those in complex humanitarian crises", "Poor governance, public distrust, and political violence", "Populations", "Poor governance, public distrust, and political violence", "reduce access to limited healthcare", "limited public health, laboratory, and primary care services", "humanitarian settings", "Frequent displacement and limited contact information", "overcrowding", "humanitarian crises", "Resources must be identified to protect healthcare workers", "Respiratory hygiene", "Respiratory hygiene", "distribution of soap to households in humanitarian settings", "rights to dignity", "alcohol-based hand rubs", "The Sphere Handbook", "reducing both bacterial and viral pathogen transmission", "prevention of illnesses transmitted by the faecal-oral route", "latrines in crisis settings are often shared and distant from residential shelters", "high risk", "Crisis-affected community engagement", "mitigation plans", "Transparent and credible information-sharing mechanisms", "Diplomacy"]